tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Dividend Date & History

1,539 Followers
Carisma Therapeutics (CARM) has no upcoming dividends

Dividend Amount Per Share​

CARM Dividend Yield Range

Currently, no data available
Please return soon. This page is being updated.

CARM Dividend History

Ex-Date
Record Date
Payment Date
Frequency
Declaration Date
Amount
Mar 08, 2023Mar 07, 2023Mar 08, 2023Not AvailableMar 03, 2023$0.36
The table shows Carisma Therapeutics’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does Carisma Therapeutics pay dividends?
Yes, CARM has paid a dividend within the past 12 months.
    How much is Carisma Therapeutics's dividend?
    Carisma Therapeutics (CARM) does not pay a dividend
    When is Carisma Therapeutics ex-dividend date?
    Carisma Therapeutics's previous ex-dividend date was on Mar 08, 2023. Carisma Therapeutics shareholders who own CARM stock before this date received Carisma Therapeutics's last dividend payment of $0.36 per share on Mar 08, 2023. CARM's next ex-dividend date has not been announced yet.
      When is Carisma Therapeutics dividend payment date?
      Carisma Therapeutics’s next quarterly payment date is on Mar 08, 2023, when Carisma Therapeutics shareholders who owned CARM shares before Mar 08, 2023 received a dividend payment of $0.36 per share. Add CARM to your watchlist to be reminded of CARM's next dividend payment.
        Does Carisma Therapeutics have sufficient earnings to cover their dividend?
        The Carisma Therapeutics has paid a dividend in the last year and may provide dividends in the near future.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis